![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 ACS Nano |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
Photo-Enhanced Chemotherapy Performance in Bladder Cancer Treatment via Albumin
Coated AIE Aggregates.
ACS Nano. 2022 Apr 12. doi: 10.1021/acsnano.1c10770.
PubMed
Abstract available
Identification of The Immune Subtype Among Muscle-invasive Bladder Cancer
Patients by Multiple Datasets.
Acta Med Indones. 2022;54:62-71.
PubMed
Abstract available
Antibiotic heliomycin and its water-soluble 4-aminomethylated derivative provoke
cell death in T24 bladder cancer cells by targeting sirtuin 1 (SIRT1).
Am J Cancer Res. 2022;12:1042-1055.
PubMed
Abstract available
FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation,
Migration, and Invasion.
Ann Clin Lab Sci. 2022;52:260-268.
PubMed
Abstract available
ASO Visual Abstract: Perineural Invasion is a Powerful Prognostic Factor for
Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
Ann Surg Oncol. 2022;29:3320-3321.
PubMed
ASO Author Reflections: Prognostic Significance of Perineural Invasion in Upper
Tract Urothelial Carcinoma.
Ann Surg Oncol. 2022;29:3318-3319.
PubMed
Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial
Carcinoma Following Radical Nephroureterectomy.
Ann Surg Oncol. 2022;29:3306-3317.
PubMed
Abstract available
CDC42 Regulates Cell Proliferation and Apoptosis in Bladder Cancer via the
IQGAP3-Mediated Ras/ERK Pathway.
Biochem Genet. 2022 Apr 12. pii: 10.1007/s10528-022-10223.
PubMed
Abstract available
Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder
Cancer.
Biomed Res Int. 2022;2022:9304552.
PubMed
Abstract available
A panel of systemic inflammatory response biomarkers for outcome prediction in
patients treated with radical cystectomy for urothelial carcinoma.
BJU Int. 2022;129:182-193.
PubMed
Abstract available
Eosinophilic cystitis complicated with cystitis glandularis: a case report.
BMC Urol. 2022;22:55.
PubMed
Abstract available
Computed tomography urography with corticomedullary phase can exclude urinary
bladder cancer with high accuracy.
BMC Urol. 2022;22:60.
PubMed
Abstract available
Biological distinction between grades 2 and 3 with respect to intravesical
recurrence in T1 high-grade bladder tumors: a retrospective study.
BMC Urol. 2022;22:59.
PubMed
Abstract available
Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.
Cancer Diagn Progn. 2021;1:245-263.
PubMed
Abstract available
Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following
Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer.
Cancer Diagn Progn. 2021;1:201-205.
PubMed
Abstract available
Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder
Cancer.
Cancers (Basel). 2022;14.
PubMed
Abstract available
FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer.
Cancers (Basel). 2022;14.
PubMed
Abstract available
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for
Muscle-Invasive Bladder Cancer-A Narrative Review.
Cancers (Basel). 2022;14.
PubMed
Abstract available
SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration
and proliferation in bladder cancer.
Cell Death Discov. 2022;8:199.
PubMed
Abstract available
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity
Moves from Bench to Bedside.
Cells. 2022;11.
PubMed
Abstract available
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic
Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.
Clin Cancer Res. 2022;28:1353-1362.
PubMed
Abstract available
Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical
Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.
Clin Genitourin Cancer. 2022;20:195.
PubMed
Abstract available
Management of Patients With Advanced Urothelial Carcinoma in an Evolving
Treatment Landscape: A Qualitative Study of Provider Perspectives of First-Line
Therapies.
Clin Genitourin Cancer. 2022;20:114-122.
PubMed
Abstract available
Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic
Characteristics and Survival Outcomes.
Clin Genitourin Cancer. 2022;20:139-147.
PubMed
Abstract available
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial
Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Clin Genitourin Cancer. 2022;20:165-175.
PubMed
Abstract available
Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With
Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma.
Clin Genitourin Cancer. 2022;20:148-154.
PubMed
Abstract available
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated
Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study.
Clin Genitourin Cancer. 2022;20:155-164.
PubMed
Abstract available
Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine
Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy
in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:196.
PubMed
Abstract available
Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma
Treated With Immunotherapy.
Clin Genitourin Cancer. 2022;20:132-138.
PubMed
Abstract available
Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune
Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor
Regimen: A Case Series.
Clin Genitourin Cancer. 2022;20:189-194.
PubMed
Abstract available
Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical
Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing
Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on
Perioperative Outcomes and
Clin Genitourin Cancer. 2022;20:198.
PubMed
Abstract available
Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk
Upper Tract Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:176-182.
PubMed
Abstract available
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder:
Multi-Institutional Cohort Analysis.
Clin Genitourin Cancer. 2022;20:e166-e172.
PubMed
Abstract available
Gender and Age Differences of Genitourinary Cancers Among Chronic Dialysis
Patients in Taiwan.
Clin Genitourin Cancer. 2022;20:e126-e134.
PubMed
Abstract available
Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and
Nutritional Determinants (BLEND) Study: Pooled analysis of 12 international
cohort studies.
Clin Nutr. 2022;41:1122-1130.
PubMed
Abstract available
Venous Thromboembolism Rate in Patients With Bladder Cancer According to the Type
of Treatment: A Systematic Review.
Cureus. 2022;14:e22945.
PubMed
Abstract available
Urothelial Bladder Carcinomas with High Tumor Mutation Burden Have a Better
Prognosis and Targetable Molecular Defects beyond Immunotherapies.
Curr Oncol. 2022;29:1390-1407.
PubMed
Abstract available
Nectin-4: a Novel Therapeutic Target for Skin Cancers.
Curr Treat Options Oncol. 2022;23:578-593.
PubMed
Abstract available
Management of Advanced Urothelial Carcinoma in Older and Frail Patients: Have
Novel Treatment Approaches Improved Their Care?
Drugs Aging. 2022;39:271-284.
PubMed
Abstract available
Definition of a Structured Training Curriculum for Robot-assisted Radical
Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus
Study Led by the ERUS Educational Board.
Eur Urol Focus. 2022;8:160-164.
PubMed
Abstract available
A Systematic Review of the Efficacy and Safety of Outpatient Bladder Tumour
Ablation.
Eur Urol Focus. 2022;8:141-151.
PubMed
Abstract available
Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at
Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based Study.
Eur Urol Focus. 2021;7:1332-1338.
PubMed
Abstract available
The Impact of Centralised Services on Metric Reflecting High-quality Performance:
Outcomes from 1110 Consecutive Radical Cystectomies at a Single Centre.
Eur Urol Focus. 2021;7:554-565.
PubMed
Abstract available
Long-term Outcomes of Cystectomy and Crossfolded Ileal Reservoir Combined with an
Afferent Tubular Segment for Heterotopic Continent Urinary Diversion: A
Longitudinal Single-centre Study.
Eur Urol Focus. 2021;7:629-637.
PubMed
Abstract available
Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
Eur Urol Focus. 2021;7:1339-1346.
PubMed
Abstract available
Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial
Carcinoma of the Bladder on Recurrence-free Survival.
Eur Urol Focus. 2021;7:1324-1331.
PubMed
Abstract available
Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed
After First-line Chemotherapy: Results of Real-life Experiences.
Eur Urol Focus. 2021;7:1061-1066.
PubMed
Abstract available
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients
with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical
Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology
Review.
Eur Urol Focus. 2021;7:1075-1083.
PubMed
Abstract available
Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep
Sequencing of Urinary DNA.
Eur Urol Oncol. 2022 Apr 8. pii: S2588-9311(22)00036.
PubMed
Abstract available
Current and emerging role of sacituzumab govitecan in the management of
urothelial carcinoma.
Expert Rev Anticancer Ther. 2022;22:335-341.
PubMed
Abstract available
Comparative Analysis of Differentially Mutated Genes in Non-Muscle and
Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome
Sequencing.
Front Genet. 2022;13:831146.
PubMed
Abstract available
SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment
Infiltration Characterization in Bladder Cancer.
Front Immunol. 2022;13:864156.
PubMed
Abstract available
Identification of glycolysis-associated long non-coding RNA regulatory subtypes
and construction of prognostic signatures by transcriptomics for bladder cancer.
Funct Integr Genomics. 2022 Apr 14. pii: 10.1007/s10142-022-00845.
PubMed
Abstract available
Int J Environ Res Public Health
Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make
It More Useful?
Int J Environ Res Public Health. 2022;19.
PubMed
Abstract available
Norcantharidin Induces Immunogenic Cell Death of Bladder Cancer Cells through
Promoting Autophagy in Acidic Culture.
Int J Mol Sci. 2022;23.
PubMed
Abstract available
Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease
Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant
Chemotherapy and Radical Cystectomy.
Int J Nanomedicine. 2022;17:1635-1646.
PubMed
Abstract available
Utility of GATA-3 and Cytokeratin 5/6 Immunostains in Separating Condyloma
Acuminatum Arising in the Urinary Tract From Non-Invasive Papillary Urothelial
Carcinoma.
Int J Surg Pathol. 2022;30:260-264.
PubMed
Abstract available
Constructing an immune- and ferroptosis-related lncRNA signature to predict the
immune landscape of human bladder cancer.
J Clin Lab Anal. 2022 Apr 14:e24389. doi: 10.1002/jcla.24389.
PubMed
Abstract available
Bone in bladder.
J Nephrol. 2022;35:1043-1044.
PubMed
Improving practice patterns in patients with newly diagnosed bladder masses
treated with transurethral resection.
J Osteopath Med. 2022;122:169-173.
PubMed
Abstract available
Open Radical Cystectomy versus Robot-Assisted Radical Cystectomy with
Intracorporeal Urinary Diversion: Early Outcomes of a Single-Center Randomized
Controlled Trial.
J Urol. 2022;207:982-992.
PubMed
Abstract available
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in
locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind,
randomised, phase 2 trial.
Lancet Oncol. 2022 Apr 11. pii: S1470-2045(22)00158.
PubMed
Abstract available
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by
converting immune-excluded into T-cell inflamed bladder tumors.
Nat Commun. 2022;13:1487.
PubMed
Abstract available
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1
blockade might predict therapy outcome in metastatic urothelial carcinoma.
Nat Commun. 2022;13:1935.
PubMed
Abstract available
Ataxia telangiectasia and Rad3-related inhibition by AZD6738 enhances
gemcitabine-induced cytotoxic effects in bladder cancer cells.
PLoS One. 2022;17:e0266476.
PubMed
Abstract available
Elucidation of CKAP4-remodeled cell mechanics in driving metastasis of bladder
cancer through aptamer-based target discovery.
Proc Natl Acad Sci U S A. 2022;119:e2110500119.
PubMed
Abstract available
KIF4A promotes tumor progression of bladder cancer via CXCL5 dependent
myeloid-derived suppressor cells recruitment.
Sci Rep. 2022;12:6015.
PubMed
Abstract available
The effects of modified RNA-binding proteins HuR on the biological behavior of
the bladder cancer T24 cell line.
Transl Androl Urol. 2022;11:348-357.
PubMed
Abstract available
Overexpression of F-box and WD repeat domain containing 7 prevents tumor growth
of bladder cancer cells through regulating SREBP1a.
Transl Androl Urol. 2022;11:367-376.
PubMed
Abstract available
Age of menarche and primary bladder cancer risk: A meta-analysis and systematic
review.
Urol Oncol. 2022 Apr 7. pii: S1078-1439(22)00074.
PubMed
Abstract available
Diagnostic performance of minichromosome maintenance 5 (MCM5) in bladder cancer:
A systematic review and meta-analysis.
Urol Oncol. 2022 Apr 9. pii: S1078-1439(22)00075.
PubMed
Abstract available
Clinicopathological significance of claspin overexpression and its efficacy as a
novel biomarker for the diagnosis of urothelial carcinoma.
Virchows Arch. 2022;480:621-633.
PubMed
Abstract available
Hospital variation in treatment patterns and oncological outcomes for patients
with muscle-invasive and metastatic bladder cancer in the Netherlands.
World J Urol. 2022 Apr 10. pii: 10.1007/s00345-022-03987.
PubMed
Abstract available
First completely robot-assisted retroperitoneal nephroureterectomy with bladder
cuff: a step-by-step technique.
World J Urol. 2022;40:1019-1026.
PubMed
Abstract available
Uncovering the role of urinary microbiota in urological tumors: a systematic
review of literature.
World J Urol. 2022;40:951-964.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by